JPMorgan Chase Boosts Teleflex Incorporated Stock Holdings

Institutional investor increases stake in medical technology company by 41.5% in Q3

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

JPMorgan Chase & Co. has increased its position in shares of Teleflex Incorporated (NYSE:TFX) by 41.5% in the 3rd quarter, according to the company's recent Form 13F filing with the Securities and Exchange Commission. The institutional investor now owns 123,343 shares of the medical technology company's stock, valued at $15,092,000.

Why it matters

This move by one of the world's largest investment banks signals increased confidence in Teleflex's future prospects within the medical technology industry. As a major shareholder, JPMorgan Chase's increased stake could provide a boost to Teleflex's stock price and overall valuation.

The details

According to the filing, JPMorgan Chase acquired an additional 36,178 shares of Teleflex during the third quarter, bringing its total ownership to 0.28% of the company's outstanding stock. Teleflex is a diversified global provider of medical technologies, specializing in critical care and surgical products used by healthcare professionals.

  • JPMorgan Chase increased its Teleflex holdings in the 3rd quarter of 2026.

The players

JPMorgan Chase & Co.

One of the world's largest investment banks and financial services companies.

Teleflex Incorporated

A diversified global provider of medical technologies, specializing in critical care and surgical products.

Got photos? Submit your photos here. ›

The takeaway

JPMorgan Chase's increased stake in Teleflex suggests the investment bank sees strong growth potential in the medical technology company's future. This move could signal positive momentum for Teleflex as it continues to innovate and expand its product offerings within the healthcare industry.